CME Group (CME) Reaches New Lifetime High Today
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
Trade-Ideas LLC identified
(
) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified CME Group as such a stock due to the following factors:
- CME has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $114.4 million.
- CME has traded 62,484 shares today.
- CME is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CME with the Ticky from Trade-Ideas. See the FREE profile for CME NOW at Trade-Ideas
More details on CME:
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The stock currently has a dividend yield of 2.1%. CME has a PE ratio of 29.0. Currently there are 4 analysts that rate CME Group a buy, 1 analyst rates it a sell, and 6 rate it a hold.
The average volume for CME Group has been 1.5 million shares per day over the past 30 days. CME Group has a market cap of $32.8 billion and is part of the financial sector and financial services industry. The stock has a beta of 0.83 and a short float of 2.5% with 5.92 days to cover. Shares are up 8.8% year-to-date as of the close of trading on Wednesday.
Analysis:
rates CME Group as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
Highlights from the ratings report include:
- The revenue growth came in higher than the industry average of 10.2%. Since the same quarter one year prior, revenues rose by 22.1%. Growth in the company's revenue appears to have helped boost the earnings per share.
- Powered by its strong earnings growth of 56.89% and other important driving factors, this stock has surged by 32.29% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, CME should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
- CME GROUP INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, CME GROUP INC increased its bottom line by earning $3.35 versus $2.93 in the prior year. This year, the market expects an improvement in earnings ($3.94 versus $3.35).
- The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Diversified Financial Services industry. The net income increased by 58.7% when compared to the same quarter one year prior, rising from $193.10 million to $306.50 million.
- You can view the full CME Group Ratings Report.
null